On August 18, Biomed Lublin announced that it was starting the production of the first batch of Polish drug for coronavirus from the plasma of convalescents. “We are the first in the world to start the production of a drug for COVID-19”, announced Lublin senator Dr. Grzegorz Czelej, one of the co-authors of the project. On September 23, the production of the first batch of the drug ended. How does this remedy work and to what extent is it effective? He told on Onet Rano.
We remind you of an excerpt from the Onet Morning program, which was broadcast in August.
As Grzegorz Czelej emphasizes in Onet Rano, Biomed from Lublin has its own technology of isolating antibodies, unique in the world, which has been used for several years. At Onet Rano, Grzegorz Czelej revealed the details of this process.
You may be interested in:
- “We are the first in the world to start the production of a COVID-19 drug”. What do we know about the drug and the Polish manufacturer?
- “I have donated the plasma four times and will continue to do so”
- Experts on the vaccine: It was a reckless and stupid decision
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.